Oxidation and modification of extracellular matrix and its role in disease

Free Radical Research

Volumn 48, Issue 9, 2014, Pages 970-989

  Chuang, C Y ^a,b   Degendorfer, G ^a,b   Davies, M J ^a,b  

^a HEART RESEARCH INSTITUTE   (Australia)

^b University of Sydney   (Australia)

Author keywords

Extracellular matrix; Glycosaminoglycan; Hypochlorous acid; Metal ions; Myeloperoxidase; Oxidative stress; Peroxynitrous acid; Protein oxidation; Proteoglycan; Radicals

Indexed keywords

ALDEHYDE; ANTIOXIDANT; BIGLYCAN; CYTOKINE; DECORIN; ENZYME; FIBRONECTIN; GLUCOSE; GLYCOSAMINOGLYCAN; GROWTH FACTOR; LAMININ; METAL ION; MYELOPEROXIDASE; NITRIC OXIDE; PERLECAN; PEROXYNITROUS ACID; SUPEROXIDE; TRANSITION ELEMENT; VERSICAN;

ARTERY WALL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CATABOLISM; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONFERENCE PAPER; DIABETES MELLITUS; EXTRACELLULAR MATRIX; GLYCOCALYX; HUMAN; MOLECULAR WEIGHT; NONHUMAN; OXIDATION; PATHOLOGY; PHOTOOXIDATION; PROTEIN BINDING; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; OXIDATION REDUCTION REACTION;

ANIMALS; CARDIOVASCULAR DISEASES; EXTRACELLULAR MATRIX; HUMANS; OXIDATION-REDUCTION;

EID: 84906062392     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2014.920087     Document Type: Conference Paper

References (192)

1. Comper WD (ed.). Extracellular Matrix. Amsterdam: Harwood Academic Press; 1996
2. Iozzo RV. Basement membrane proteoglycans: From cellar to ceiling. Nat Rev Mol Cell Biol 2005 6 646-656
3. Rees MD, Kennett EC, Whitelock JM, Davies MJ. Oxidative damage to extracellular matrix and its role in human pathologies. Free Radic Biol Med 2008; 44: 1973-2001
4. Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA. The degradation of human endothelial cell-derived perlecan and release of bound basic fi broblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 1996 271 10079-10086
5. Fu X, Kassim SY, Parks WC, Heinecke JW. Hypochlorous acid oxygenates the cysteine switch domain of pro- matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 2001 276 41279-41287
6. Wang Y, Rosen H, Madtes DK, Shao B, Martin TR, Heinecke JW, Fu X. Myeloperoxidase inactivates TIMP-1 by oxidizing its N -Terminal cysteine residue: An oxidative mechanism for regulating proteolysis during infl ammation. J Biol Chem 2007 282 31826-31834
7. Whitelock JM, Iozzo RV. Heparan sulfate: A complex polymer charged with biological activity. Chem Rev 2005 105 2745-2764
8. Murdoch AD, Dodge GR, Cohen I, Tuan RS, Iozzo RV. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J Biol Chem 1992 267 8544-8557
9. Whitelock JM, Melrose J, Iozzo RV. Diverse cell signaling events modulated by perlecan. Biochemistry 2008 47 11174-11183
10. Knox S, Fosang AJ, Last K, Melrose J, Whitelock J. Perlecan from human epithelial cells is a hybrid heparan/chondroitin/ keratan sulfate proteoglycan. FEBS Lett 2005; 579: 5019-5023
11. Whitelock JM, Graham LD, Melrose J, Murdoch AD, Iozzo RV, Underwood PA. Human perlecan immunopurifi ed from diff erent endothelial cell sources has diff erent adhesive properties for vascular cells. Matrix Biol 1999 18 163-178
12. Chuang CY, Lord MS, Melrose J, Rees MD, Knox SM, Freeman C, et al. Heparan sulfate-dependent signaling of fi broblast growth factor 18 by chondrocyte-derived perlecan. Biochemistry 2010 49 5524-5532
13. Hacker U, Nybakken K, Perrimon N. Heparan sulphate proteoglycans: The sweet side of development. Nat Rev Mol Cell Biol 2005 6 530-541
14. Theocharis AD, Tsolakis I, Hjerpe A, Karamanos NK. Human abdominal aortic aneurysm is characterized by decreased versican concentration and specifi c downregulation of versican isoform V(0). Atherosclerosis 2001 154 367-376
15. Merrilees MJ, Beaumont B, Scott LJ. Comparison of deposits of versican, biglycan and decorin in saphenous vein and internal thoracic, radial and coronary arteries: Correlation to patency. Coronary Artery Dis 2001 12 7-16
16. Ito K, Shinomura T, Zako M, Ujita M, Kimata K. Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J Biol Chem 1995 270 958-965
17. Sch o nherr E, J a rvel a inen HT, Sandell LJ, Wight TN. Eff ects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem 1991 266 17640-17647
18. Wight TN, Merrilees MJ. Proteoglycans in atherosclerosis and restenosis: Key roles for versican. Circ Res 2004 94 1158-1167
19. Wagner WD, Salisbury GJ, Rowe HA. A proposed structure of chondroitin 6-sulfate proteoglycan of human normal and adjacent atherosclerotic plaque. Arteriosclerosis 1986 6 407-417
20. Dalferes ER Jr, Radhakrishnamurthy B, Ruiz HA, Berenson GS. Composition of proteoglycans from human atherosclerotic lesions. Exp Mol Pathol 1987 47 363-376
21. Cherchi GM, Coinu R, Demuro P, Formato M, Sanna G, Tidore M, et al. Structural and functional modifi cations of human aorta proteoglycans in atherosclerosis. Matrix 1990 10 362-372
22. Yamakawa T, Bai HZ, Masuda J, Sawa Y, Shirakura R, Ogata J, Matsuda H. Diff erential expression of proteoglycans biglycan and decorin During neointima formation after stent implantation in normal and atherosclerotic rabbit aortas. Atherosclerosis 2000 152 287-298
23. Olin-Lewis K, Krauss RM, La Belle M, Blanche PJ, Barrett PHR, Wight TN, Chait A. ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan. J Lipid Res 2002; 43: 1969-1977
24. O 'Brien KD, Lewis K, Fischer JW, Johnson P, Hwang JY, Knopp EA, et al. Smooth muscle cell biglycan overexpression results in increased lipoprotein retention on extracellular matrix: Implications for the retention of lipoproteins in atherosclerosis. Atherosclerosis 2004 177 29-35
25. Kunjathoor VV, Chiu DS, O 'Brien KD, LeBoeuf RC. Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis. Arterioscler Thromb Vasc Biol 2002 22 462-468
26. Williams KJ. Arterial wall chondroitin sulfate proteoglycans: Diverse molecules with distinct roles in lipoprotein retention and atherogenesis. Curr Opin Lipidol 2001; 12: 477-487
27. Radhakrishnamurthy B, Tracy RE, Dalferes ER Jr, Berenson GS. Proteoglycans in human coronary arteriosclerotic lesions. Exp Mol Pathol 1998 65 1-8
28. Evanko SP, Raines EW, Ross R, Gold LI, Wight TN. Proteoglycan Distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. Am J Pathol 1998 152 533-546
29. Strom A, Ahlqvist E, Franzen A, Heinegard D, Hultgardh-Nilsson A. Extracellular matrix components in atherosclerotic arteries of Apo E/LDL receptor defi cient mice: An immunohistochemical study. Histol Histopathol 2004; 19: 337-347
30. Kolodgie FD, Burke AP, Farb A, Weber DK, Kutys R, Wight TN, Virmani R. Diff erential accumulation of proteoglycans and hyaluronan in culprit lesions: Insights into plaque erosion . Arterioscler Thromb Vasc Biol 2002 22 1642-1648
31. Al Haj Zen A, Caligiuri G, Sainz J, Lemitre M, Demerens C, Lafont A. Decorin overexpression reduces atherosclerosis development in apolipoprotein E-defi cient mice. Atherosclerosis 2006 187 31-39
32. Takahashi S, Leiss M, Moser M, Ohashi T, Kitao T, Heckmann D, et al. The RGD motif in fi bronectin is essential for development but dispensable for fi bril assembly. J Cell Biol 2007 178 167-178
33. Cho J, Mosher DF. Enhancement of thrombogenesis by plasma fi bronectin cross-linked to fi brin and assembled in platelet thrombi. Blood 2006 107 3555-3563
34. Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci 2002 115 3861-3863
35. Allio AE, McKeown-Longo PJ. Extracellular matrix assembly of cell-derived and plasma-derived fi bronectins by substrate-Attached fi broblasts. J Cell Physiol 1988; 135: 459-466
36. Gui L, Wojciechowski K, Gildner CD, Nedelkovska H, Hocking DC. Identifi cation of the heparin-binding determinants within fi bronectin repeat III1: Role in cell spreading and growth. J Biol Chem 2006 281 34816-34825
37. Rozario T, Dzamba B, Weber GF, Davidson LA, DeSimone DW. The physical state of fi bronectin matrix diff erentially regulates morphogenetic movements in vivo. Dev Biol 2009 327 386-398
38. Wang R, Clark RA, Mosher DF, Ren XD. Fibronectin 's central cell-binding domain supports focal adhesion formation and Rho signal transduction. J Biol Chem 2005 280 28803-28810
39. Thyberg J, Hultgardh-Nilsson A. Fibronectin and the basement membrane components laminin and collagen type IV infl uence the phenotypic properties of subcultured rat aortic smooth muscle cells diff erently. Cell Tissue Res 1994 276 263-271
40. Aumailley M, Bruckner-Tuderman L, Carter WG, Deutzmann R, Edgar D, Ekblom P, et al. A simplifi ed laminin nomenclature. Matrix Biol 2005 24 326-332
41. Colognato H, Yurchenco PD. Form and function: The laminin family of heterotrimers. Dev Dyn 2000 218 213-234
42. Hamill KJ, Kligys K, Hopkinson SB, Jones JCR. Laminin Deposition in the extracellular matrix: A complex picture emerges. J Cell Sci 2009 122 4409-4417
43. Beck K, Hunter I, Engel J. Structure and function of laminin: Anatomy of a multidomain glycoprotein. FASEB J 1990 4 148-160
44. Miner JH, Li C, Mudd JL, Go G, Sutherland AE. Compositional and structural requirements for laminin and basement membranes during mouse embryo implantation and gastrulation . Development 2004 131 2247-2256
45. Smyth N, Vatansever HS, Murray P, Meyer M, Frie C, Paulsson M, Edgar D. Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm diff erentiation. J Cell Biol 1999 144 151-160
46. Petajaniemi N, Korhonen M, Kortesmaa J, Tryggvason K, Sekiguchi K, Fujiwara H, et al. Localization of laminin alpha4-chain in Developing and adult human tissues. J Histochem Cytochem 2002; 50: 1113-1130
47. Thyboll J, Kortesmaa J, Cao R, Soininen R, Wang L, Iivanainen A, et al. Deletion of the laminin alpha4 chain leads to impaired microvessel maturation. Mol Cell Biol 2002 22 1194-1202
48. Miner JH, Cunningham J, Sanes JR. Roles for laminin in embryogenesis: Exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain. J Cell Biol 1998 143 1713-1723
49. Scheele S, Nystrom A, Durbeej M, Talts JF, Ekblom M, Ekblom P. Laminin isoforms in Development and disease. J Mol Med (Berl) 2007 85 825-836
50. Maghzal GJ, Krause KH, Stocker R, Jaquet V. Detection of reactive oxygen species derived from the family of NOX NADPH oxidases. Free Radic Biol Med 2012; 53: 1903-1918
51. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 2007 87 245-313
52. Xia Y, Zweier JL. Substrate control of free radical generation from xanthine oxidase in the postischemic heart. J Biol Chem 1995 270 18797-18803
53. Babior BM, Lambeth JD, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 2002; 397: 342-344
54. Ignarro LJ. Nitric oxide: A unique endogenous signaling molecule in vascular biology. Biosci Rep 1999 19 51-71
55. Radomski MW, Palmer RM, Moncada S. An L-Arginine/ nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A 1990 87 5193-5197
56. Squadrito GL, Pryor WA. Oxidative chemistry of nitric oxide: The roles of superoxide, peroxynitrite, and carbon Dioxide. Free Radic Biol Med 1998; 25: 392-403
57. Kone BC. Nitric oxide in renal health and disease. Am J Kidney Dis 1997 30 311-333
58. Vasquez-Vivar J, Kalyanaraman B, Martasek P. The role of tetrahydrobiopterin in superoxide generation from eNOS: Enzymology and physiological implications. Free Radic Res 2003 37 121-127
59. Huie RE, Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun 1993; 18: 195-199
60. Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry . Biol Chem Hoppe Seyler 1994 375 81-88
61. Good PF, Hsu A, Werner P, Perl DP, Olanow CW. Protein nitration in Parkinson 's disease. J Neuropath Exp Neurol 1998 57 338-342
62. Smith MA, Harris PLR, Sayre LM, Beckman JS, Perry G. Widespread peroxynitrite-mediated damage in Alzheimer 's disease. J Neurosci 1997 17 2653-2657
63. Radi R, Peluff o G, Alvarez MN, Naviliat M, Cayota A. Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 2001; 30: 463-488
64. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990 87 1620-1624
65. Ferrer-Sueta G, Radi R. Chemical biology of peroxynitrite: Kinetics, diff usion, and radicals. ACS Chem Biol 2009 4 161-177
66. Quijano C, Castro L, Peluff o G, Valez V, Radi R. Enhanced mitochondrial superoxide in hyperglycemic endothelial cells: Direct measurements and formation of hydrogen peroxide and peroxynitrite. Am J Physiol Heart Circ Physiol 2007 293 H3404-H3414
67. Alvarez MN, Trujillo M, Radi R. Peroxynitrite formation from biochemical and cellular fl uxes of nitric oxide and superoxide. Methods Enzymol 2002 359 353-366
68. Carballal S, Bartesaghi S, Radi R. Kinetic and mechanistic considerations to assess the biological fate of peroxynitrite. Biochim Biophys Acta 2013 1840 768-780
69. Goldstein S, Czapski G. Direct and indirect oxidations by peroxynitrite. Inorg Chem 1995 34 4041-4048
70. Gerasimov OV, Lymar SV. The yield of hydroxyl radical from the decomposition of peroxynitrous acid. Inorg Chem 1999 38 4317-4321
71. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991 266 4244-4250
72. Ferrer-Sueta G, Batinic-Haberle I, Spasojevic I, Fridovich I, Radi R. Catalytic scavenging of peroxynitrite by isomeric Mn(III) N- methylpyridylporphyrins in the presence of reductants. Chem Res Toxicol 1999 12 442-449
73. Lymar SV, Hurst JK. Radical nature of peroxynitrite reactivity . Chem Res Toxicol 1998 11 714-715
74. Bonini MG, Radi R, Ferrer-Sueta G, Ferreira AM, Augusto O. Direct EPR detection of the carbonate radical anion produced from peroxynitrite and carbon Dioxide. J Biol Chem 1999 274 10802-10806
75. Denicola A, Freeman BA, Trujillo M, Radi R. Peroxynitrite reaction with carbon Dioxide/bicarbonate: Kinetics and infl uence on peroxynitrite-mediated oxidations. Arch Biochem Biophys 1996 333 49-58
76. Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H, Beckman JS. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol 1992 5 834-842
77. Santos CX, Bonini MG, Augusto O. Role of the carbonate radical anion in tyrosine nitration and hydroxylation by peroxynitrite . Arch Biochem Biophys 2000 377 146-152
78. Szabo C, Ohshima H. DNA damage induced by peroxynitrite: Subsequent biological eff ects. Nitric Oxide 1997 1 373-385
79. Moore KP, Darley-Usmar V, Morrow J, Roberts LJ II. Formation of F2-isoprostanes during oxidation of human lowdensity lipoprotein and plasma by peroxynitrite. Circ Res 1995 77 335-341
80. Kennett EC, Rees MD, Malle E, Hammer A, Whitelock JM, Davies MJ. Peroxynitrite modifi es the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains. Free Radic Biol Med 2010; 49: 282-293
81. Kennett EC, Davies MJ. Glycosaminoglycans are fragmented by hydroxyl, carbonate, and nitrogen Dioxide radicals in a site-selective manner: Implications for peroxynitrite-mediated damage at sites of infl ammation. Free Radic Biol Med 2009 47 389-400
82. Kennett E, Chuang CY, Degendorfer G, Rees MD, Hammer A, Malle E, et al. Extracellular matrix proteoglycans are a major target for peroxynitrite in the artery wall. Free Radic Biol Med 2010 49 S113
83. Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun 2003 305 776-783
84. Ischiropoulos H, al-mehdi AB. Peroxynitrite-mediated oxidative protein modifi cations. FEBS Lett 1995 364 279-282
85. Leeuwenburgh C, Hardy MM, Hazen SL, Wagner P, Oh-ishi S, Steinbrecher UP, Heinecke JW. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem 1997; 272: 1433-1436
86. Baldus S, Eiserich JP, Brennan ML, Jackson RM, Alexander CB, Freeman BA. Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in infl ammatory diseases. Free Radic Biol Med 2002; 33: 1010-1019
87. Vadseth C, Souza JM, Thomson L, Seagraves A, Nagaswami C, Scheiner T, et al. Pro-Thrombotic state induced by posttranslational modifi cation of fi brinogen by reactive nitrogen species. J Biol Chem 2004 279 8820-8826
88. van Der Veen BS, de Winther MP, Heeringa P. Myeloperoxidase: Molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 2009 11 2899-2937
89. Davies MJ, Hawkins CL, Pattison DI, Rees MD. Mammalian heme peroxidases: From molecular mechainsms to health implications. Antioxid Redox Signal 2008 10 1199-1234
90. Davies MJ. Myeloperoxidase-derived oxidation: Mechanisms of biological damage and its prevention. J Clin Biochem Nutr 2011 48 8-19
91. Daugherty A, Dunn J, Rateri D, Heinecke J. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994 94 437-444
92. Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A, et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002 296 2391-2394
93. H azen S L, H einecke J W. 3 -Chlorotyrosine, a specifi c marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 1997 99 2075-2081
94. Malle E, Waeg G, Schreiber R, Grone EF, Sattler WS, Grone HJ. Immunohistochemical evidence for the myeloperoxidase/ H 2 O 2 /halide system in human atherosclerotic lesions -colocalization of myeloperoxidase and hypochloritemodifi ed proteins. Eur J Biochem 2000 267 4495-4503
95. Takeshita J, Byun J, Nhan TQ, Pritchard DK, Pennathur S, Schwartz SM, et al. Myeloperoxidase generates 5-chlorouracil in human atherosclerotics tissue: A potential pathway for somatic mutagenesis by macrophages. J Biol Chem 2005 281 3096-3104
96. Pattison DI, Davies MJ, Hawkins CL. Reactions and reactivity of myeloperoxidase-derived oxidants: Diff erential biological eff ects of hypochlorous and hypothiocyanous acids. Free Radic Res 2012; 46: 975-995
97. Thomas EL, Grisham MB, Jeff erson MM. Cytotoxicity of chloramines. Meth Enzymol 1986 132 585-593
98. Rees MD, Davies MJ. Heparan sulfate degradation via reductive homolysis of its N -chloro derivatives. J Am Chem Soc 2006 128 3085-3097
99. Hawkins CL, Davies MJ. Hypochlorite-induced damage to proteins: Formation of N-centred radicals from lysine residues and their role in protein fragmentation. Biochem J 1998 332 617-625
100. Hawkins CL, Davies MJ. Hypochlorite-induced oxidation of proteins in plasma: Formation of chloramines and nitrogencentred radicals and their role in protein fragmentation. Biochem J 1999 340 539-548
101. Pattison DI, O 'Reilly RJ, Skaff O, Radom L, Anderson RF, Davies MJ. One-electron reduction of N-chlorinated and N-brominated species is a source of radicals and bromine atom formation. Chem Res Toxicol 2011 24 371-382
102. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 4th ed. Oxford: Oxford University Press; 2007. pp. 1-704
103. Stadler N, Lindner RA, Davies MJ. Direct detection and quantifi cation of transition metal ions in human atherosclerotic plaques: Evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol 2004 24 949-954
104. Fu S, Davies MJ, Stocker R, Dean RT. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J 1998 333 519-525
105. Stanley N, Stadler N, Woods AA, Bannon PG, Davies MJ. Concentrations of iron correlate with the extent of protein, but not lipid, oxidation in advanced human atherosclerotic lesions. Free Radic Biol Med 2006; 40: 1636-1643
106. Verzijl N, DeGroot J, Oldehinkel E, Bank RA, Thorpe SR, Baynes JW, et al. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J 2000 350 381-387
107. Pattison DI, Rahmanto AS, Davies MJ. Photo-oxidation of proteins. Photochem Photobiol Sci 2012; 11: 38-53
108. Lesley J, Hascall VC, Tammi M, Hyman R. Hyaluronan binding by cell surface CD44. J Biol Chem 2000 275 26967-26975
109. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: Role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 2002; 106: 3073-3078
110. von Sonntag C. Free radical reactions of carbohydrates as studied by radiation techniques. Adv Carbohydr Chem Biochem 1980 37 7-77
111. Kennett EC, Davies MJ. Degradation of matrix glycosaminoglycans by peroxynitrite/peroxynitrous acid: Evidence for a hydroxyl-radical-like mechanism. Free Radic Biol Med 2007 42 1278-1289
112. Davies MJ, Gilbert BC. Free radical reactions: Fragmentation and rearrangements in aqueous solution. Adv Detailed React Mech 1991 1 35-81
113. Rees MD, Hawkins CL, Davies MJ. Hypochlorite-mediated fragmentation of hyaluronan, chondroitin sulfates, and related N-Acetyl glycosamines: Evidence for chloramide intermediates, free radical transfer reactions, and site-specifi c fragmentation . J Am Chem Soc 2003 125 13719-13733
114. Parsons BJ, Sibanda S, Heyes DJ, Paterson AW. Reaction of superoxide radicals with glycosaminoglycan chloramides: A kinetic study. Free Radic Biol Med 2013; 61C: 111-118
115. Sibanda S, Akeel A, Martin SW, Paterson AW, Edge R, Al-Assaf S, Parsons BJ. Effi ciencies of fragmentation of glycosaminoglycan chloramides of the extracellular matrix by oxidising and reducing radicals: Potential site-specifi c targets in infl ammation?. Free Radic Biol Med 2013; 65: 280-290
116. Sibanda S, Parsons BJ, Houee-Levin C, Marignier JL, Paterson AW, Heyes DJ. One-electron oxidation and reduction of glycosaminoglycan chloramides: A kinetic study. Free Radic Biol Med 2013; 63: 126-134
117. Al-Assaf S, Navaratnam S, Parsons BJ, Phillips GO. Chain scission of hyaluronan by peroxynitrite. Arch Biochem Biophys 2003 411 73-82
118. Al-Assaf S, Navaratnam S, Parsons BJ, Phillips GO. Chain scission of hyaluronan by carbonate and dichloride radical anions: Potential reactive species in infl ammation?. Free Radic Biol Med 2006 40 2018-2027
119. Alvarez B, Radi R. Peroxynitrite reactivity with amino acids and proteins. Amino Acids 2003 25 295-311
120. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007 87 315-424
121. Yamakura F, Taka H, Fujimura T, Murayama K. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 1998 273 14085-14089
122. Hawkins CL, Davies MJ. Generation and propagation of radical reactions on proteins. Biochim Biophys Acta 2001 1504 196-219
123. Davies MJ. The oxidative environment and protein Damage. Biochim Biophys Acta 2005 1703 93-109
124. Pattison DI, Davies MJ. Absolute rate constants for the reaction of hypochlorous acid with protein side-chains and peptide bonds. Chem Res Toxicol 2001 14 1453-1464
125. Pattison DI, Davies MJ. Reactions of myeloperoxidasederived oxidants with biological substrates: Gaining chemical insight into human infl ammatory diseases. Curr Med Chem 2006 13 3271-3290
126. Winterbourn CC, Kettle AJ. Biomarkers of myeloperoxidasederived hypochlorous acid. Free Radic Biol Med 2000 29 403-409
127. Herold S. Nitrotyrosine, dityrosine, and nitrotryptophan formation from metmyoglobin, hydrogen peroxide, and nitrite. Free Radic Biol Med 2004; 36: 565-579
128. Stocker R, Keaney JF Jr. Role of oxidative modifi cations in atherosclerosis. Physiol Rev 2004 84 1381-1478
129. Woods AA, Linton SM, Davies MJ. Detection of HOClmediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. Biochem J 2003 370 729-735
130. Nakashima Y, Fujii H, Sumiyoshi S, Wight TN, Sueishi K. Early human atherosclerosis: Accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infi ltration. Arterioscler Thromb Vasc Biol 2007 27 1159-1165
131. Kinsella MG, Tran PK, Weiser-Evans MC, Reidy M, Majack RA, Wight TN. Changes in perlecan expression During vascular injury-role in the inhibition of smooth muscle cell proliferation in the late lesion. Arterioscler Thromb Vasc Biol 2003 23 608-614
132. Geary RL, Wong JM, Rossini A, Schwartz SM, Adams LD. Expression profi ling identifi es 147 genes contributing to a unique primate neointimal smooth muscle cell phenotype. Arteri oscler Thromb Vasc Biol 2002 22 2010-2016
133. Theocharis AD, Tsolakis I, Tsegenidis T, Karamanos NK. Human abdominal aortic aneurysm is closely related with compositional and specifi c structural modifi cations at the glycosaminoglycan level. Atherosclerosis 1999; 145: 359-368
134. Lord MS, Chuang CY, Melrose J, Davies MJ, Iozzo RV, Whitelock JM. The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling. Matrix Biol 2014; doi: 10.1016/j.matbio.2014.01.016
135. Srinivasan SR, Vijayagopal P, Eberle K, Radhakrishnamurthy B, Berenson GS. Low-density lipoprotein binding affi nity of arterial wall proteoglycans: Characteristics of a chondroitin sulfate proteoglycan subfraction. Biochim Biophys Acta 1989; 1006: 159-166
136. Tran PK, Agardh HE, Tran-Lundmark K, Ekstrand J, Roy J, Henderson B, et al. Reduced perlecan expression and accumulation in human carotid atherosclerotic lesions. Atherosclerosis 2007 190 264-270
137. Pillarisetti S, Paka L, Obunike JC, Berglund L, Goldberg IJ. Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix. J Clin Invest 1997 100 867-874
138. Tran PK, Tran-Lundmark K, Soininen R, Tryggvason K, Thyberg J, Hedin U. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-defi cient perlecan. Circ Res 2004; 94: 550-558
139. Kinsella MG, Irvin C, Reidy MA, Wight TN. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries. Atherosclerosis 2004 175 51-57
140. Tran-Lundmark K, Tran PK, Paulsson-Berne G, Frid e n V, Soininen R, Tryggvason K, et al. Heparan sulfate in perlecan promotes mouse atherosclerosis: Roles in lipid permeability, lipid retention, and smooth muscle cell proliferation. Circ Res 2008 103 43-52
141. Barash U, Cohen-Kaplan V, Dowek I, Sanderson RD, Ilan N, Vlodavsky I. Proteoglycans in health and disease: New concepts for heparanase function in tumor progression and metastasis. FEBS J 2010 277 3890-3903
142. Okada Y, Yamada S, Toyoshima M, Dong J, Nakajima M, Sugahara K. Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis -hierarchical sulfate groups with diff erential eff ects and the essential target disulfated trisaccharide sequence. J Biol Chem 2002 277 42488-42495
143. Peterson SB, Liu J. Multi-faceted substrate specifi city of heparanase. Matrix Biol 2013 32 223-227
144. Baker AB, Chatzizisis YS, Beigel R, Jonas M, Stone BV, Coskun AU, et al. Regulation of heparanase expression in coronary artery disease in Diabetic, hyperlipidemic swine. Atherosclerosis 2010 213 436-442
145. O sterholm C, Folkersen L, Lengquist M, Pont e n F, Renn e T, Li JP, Hedin U. Increased expression of heparanase in symptomatic carotid atherosclerosis. Atherosclerosis 2013 226 67-73
146. Vlodavsky I, Blich M, Li JP, Sanderson RD, Ilan N. Involvement of heparanase in atherosclerosis and other vessel wall pathologies. Matrix Biol 2013 32 241-251
147. Blich M, Golan A, Arvatz G, Sebbag A, Shafat I, Sabo E, et al. Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression. Arterioscler Thromb Vasc Biol 2013 33 e56-e65
148. Chen G, Wang D, Vikramadithyan R, Yagyu H, Saxena U, Pillarisetti S, Goldberg IJ. Infl ammatory cytokines and fatty acids regulate endothelial cell heparanase expression. Biochemistry 2004 43 4971-4977
149. Woods AA, Davies MJ. Evidence for HOCl-mediated oxidation of extracellular matrix proteins in human atherosclerotic plaques. Clin Exp Pharmacol Physiol 2003 30 A16
150. Jones GT, Jiang F, McCormick SP, Dusting GJ. Elastic lamina defects are an early feature of aortic lesions in the apolipoprotein E knockout mouse. J Vasc Res 2005 42 237-246
151. Chuang CY, Degendorfer G, Hammer A, Whitelock JM, Malle E, Davies MJ. Oxidation modifi es the structure and function of the extracellular matrix generated by human coronary artery endothelial cells. Biochem J 2014 459 313-322
152. Kennett EC, Davies MJ. Degradation of extracellular matrix by peroxynitrite/peroxynitrous acid. Free Radic Biol Med 2008 45 716-725
153. Zabucchi G, Soranzo M, Menegazzi R, Bertoncin P, Nardon E, Patriarca P. Uptake of human eosinophil peroxidase and myeloperoxidase by cells involved in the infl ammatory process. J Histochem Cytochem 1989; 37: 499-508
154. Baldus S, Eiserich JP, Mani A, Castro L, Figueroa M, Chumley P, et al. Endothelial transcytosis of myeloperoxidase confers specifi city to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 2001 108 1759-1770
155. Woods AA, Davies MJ. Fragmentation of extracellular matrix by hypochlorous acid. Biochem J 2003 376 219-227
156. Rees MD, Whitelock JM, Malle E, Chuang CY, Iozzo RV, Nilasaroya A, Davies MJ. Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan. Matrix Biol 2010 29 63-73
157. McGowan SE. Mechanisms of extracellular matrix proteoglycan Degradation by human neutrophils. Am J Respir Cell Mol Biol 1990 2 271-279
158. Klebanoff SJ, Kinsella MG, Wight TN. Degradation of endothelial cell matrix heparan sulfate proteoglycan by elastase and the myeloperoxidase-H 2 O 2 -chloride system. Am J Pathol 1993 143 907-917
159. Vissers MC, Thomas C. Hypochlorous acid disrupts the adhesive properties of subendothelial matrix. Free Radic Biol Med 1997 23 401-411
160. Sugiyama S, Kugiyama K, Aikawa M, Nakamura S, Ogawa H, Libby P. Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: Involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 2004 24 1309-1314
161. McGowan SE, Murray JJ. Direct eff ects of neutrophil oxidants on elastase-induced extracellular matrix proteolysis. Am Rev Resp Dis 1987 135 1286-1293
162. Vissers MCM, Winterbourn CC. The eff ect of oxidants on neutrophil-mediated degradation of glomerular basement membrane collagen. Biochim Biophys Acta 1986 889 277-286
163. Weiss SJ, Regiani S. Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinases and oxygen metabolites. J Clin Invest 1984 73 1297-1303
164. Cantor JO, Shteyngart B, Cerreta JM, Ma SR, Turino GM. Synergistic eff ect of hydrogen peroxide and elastase on elastic fi ber injury in vitro. Exp Biol Med 2006 231 107-111
165. Tiku ML, Shah R, Allison GT. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein Degradation -possible role in cartilage aging and the pathogenesis of osteoarthritis . J Biol Chem 2000 275 20069-20076
166. Wang K, Xu SJ, Zhang FH, Wang CX, Chang SY, Zhang JY, et al. Free-radicals induced abnormal chondrocytes, matrix and mineralization-A new concept of Kaschin-Becks disease . Chin Med J 1991 104 307-312
167. Riedle B, Kerjaschki D. Reactive oxygen species cause direct damage of Engelbreth-Holm-Swarm matrix. Am J Pathol 1997 151 215-231
168. Raats CJ, Bakker MA, van Den Born J, Berden JH. Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome. J Biol Chem 1997 272 26734-26741
169. Pazos MDC, Nader HB. Eff ect of photodynamic therapy on the extracellular matrix and associated components. Braz J Med Biol Res 2007 40 1025-1035
170. LaMuraglia GM, Adili F, Karp SJ, Statius van Eps RG, Watkins MT. Photodynamic therapy inactivates extracellular matrix-basic fi broblast growth factor: Insights to its eff ect on the vascular wall. J Vasc Surg 1997 26 294-301
171. Elgawish A, Glomb M, Friedlander M, Monnier VM. Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. J Biol Chem 1996 271 12964-12971
172. Fu MX, Knecht KJ, Thorpe SR, Baynes JW. Role of oxygen in cross-linking
173. Fu MX, Wells-knecht KJ, Blackledge JA, Lyons TJ, Thorpe SR, Baynes JW. Glycation, glycoxidation, and crosslinking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard Reaction. Diabetes 1994 43 676-683
174. Sajithlal GB, Chithra P, Chandrakasan G. An in vitro study on the role of metal catalyzed oxidation in glycation and crosslinking of collagen. Mol Cell Biochem 1999 194 257-263
175. Weiss SJ, Curnutte JT, Regiani S. Neutrophil-mediated solubilization of the subendothelial matrix: Oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes. J Immunol 1986 136 636-641
176. Grone HJ, Grone EF, Malle E. Immunohistochemical detection of hypochlorite-modifi ed proteins in glomeruli of human membranous glomerulonephritis. Lab Invest 2002; 82: 5-14
177. Laurent TC, Laurent UB, Fraser JR. Functions of hyaluronan . Ann Rheum Dis 1995 54 429-432
178. Horton MR, Boodoo S, Powell JD. NF-kB activation mediates the cross-Talk between extracellular matrix and interferon- β(IFN- β) leading to enhanced monokine induced by IFN- β(MIG) expression in macrophages. J Biol Chem 2002 277 43757-43762
179. Takahashi Y, Li L, Kamiryo M, Asteriou T, Moustakas A, Yamashita H, Heldin P. Hyaluronan fragments induce endothelial cell diff erentiation in a CD44- And CXCL1/GRO1-dependent manner. J Biol Chem 2005; 280: 24195-24204
180. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004 279 17079-17084
181. Ibrahim S, Ramamurthi A. Hyaluronic acid cues for functional endothelialization of vascular constructs. J Tissue Eng Regen Med 2008 2 22-32
182. Cuff CA, Kothapalli D, Azonobi I, Chun S, Zhang Y, Belkin R, et al. The adhesion receptor CD44 promotes atherosclerosis by mediating infl ammatory cell recruitment and vascular cell activation. J Clin Invest 2001; 108: 1031-1040
183. Kramsch DM, Franzblau C, Hollander W. Components of the protein-lipid complex of arterial elastin: Their role in the retention of lipid in atherosclerotic lesions. Adv Exp Medic Biol 1974 43 193-210
184. McKee CM, Lowenstein CJ, Horton MR, Wu J, Bao C, Chin BY, et al. Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kBdependent mechanism. J Biol Chem 1997; 272: 8013-8018
185. VanTeeff elen JW, Brands J, Stroes ES, Vink H. Endothelial glycocalyx: Sweet shield of blood vessels. Trends Cardiovasc Med 2007 17 101-105
186. van Golen RF, Reiniers MJ, Vrisekoop N, Zuurbier CJ, Olthof PB, van Rheenen J, et al. The mechanisms and physiological relevance of glycocalyx degradation in hepatic ischemia/reperfusion injury. Antioxid Redox Signal 2014 doi: 10.1089/ars.2013.5751
187. Nieuwdorp M, van Haeften TW, Gouverneur M, Mooij HL, van Lieshout MHP, Levi M, et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 2006 55 480-486
188. Czarnowska E, Karwatowska-Prokopczuk E. Ultrastructural demonstration of endothelial glycocalyx disruption in the reperfused rat-heart-involvement of oxygen-free radicals. Basic Res Cardiol 1995 90 357-364
189. Kurzelewski M, Czarnowska E, Beresewicz A. Superoxideand nitric oxide-derived species mediate endothelial dysfunction, endothelial glycocalyx disruption, and enhanced neutrophil adhesion in the post-ischemic guinea-pig heart. J Physiol Pharmacol 2005 56 163-178
190. Vissers MC, Day WA, Winterbourn CC. Neutrophils adherent to a nonphagocytosable surface (glomerular basement membrane) produce oxidants only at the site of attachment. Blood 1985 66 161-166
191. Vissers MC, Winterbourn CC, Hunt JS. Degradation of glomerular basement-membrane by human-neutrophils in vitro. Biochim Biophys Acta 1984 804 154-160
192. Janusz MJ, Doherty NS. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin-G. J Immunol 1991 146 3922-3928.